Skip to content

Category: GDP

CANNABINOIDS IN EPILEPSY

CANNABINOIDS IN EPILEPSY

26 February 2024

Epilepsy is one of the most common neurological disorders, affecting around 70 million people worldwide. 65% of patients are managed with antiepileptic drugs and lead a normal life but, what about the remaining 35%? These patients suffer from refractory epilepsy , signi...

Newsletter

Stay up to date with Agropharm

News about our projects, regulations and the cannabis industry. No spam: unsubscribe at any time.